Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.
2.
3.

Direct non-genomic effect of steroid hormones on superoxide anion generation in the bone resorbing osteoclasts.

Berger CE, Horrocks BR, Datta HK.

Mol Cell Endocrinol. 1999 Mar 25;149(1-2):53-9.

PMID:
10375017
4.
5.

Calcitonin-like effects of forskolin and choleratoxin on surface area and motility of isolated rabbit osteoclasts.

Ransjö M, Lerner UH, Heersche JN.

J Bone Miner Res. 1988 Dec;3(6):611-9.

PMID:
3251398
6.

Forskolin augments the effects of calcitonin on cytoplasmic spreading of isolated rat osteoclasts and plasma calcium levels in the rat.

Nicholson GC, Yumita S, Moseley JM, Yates AJ, Martin TJ.

J Bone Miner Res. 1988 Apr;3(2):181-4.

PMID:
3213613
7.

Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts.

Lundberg P, Lie A, Bjurholm A, Lehenkari PP, Horton MA, Lerner UH, Ransjö M.

Bone. 2000 Dec;27(6):803-10.

PMID:
11113391
9.

Calcitonin stimulates cAMP accumulation in chicken osteoclasts.

Rifkin BR, Auszmann JM, Kleckner AP, Vernillo AT, Fine AS.

Life Sci. 1988;42(7):799-804.

PMID:
2828805
10.

Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor.

Mano M, Arakawa T, Mano H, Nakagawa M, Kaneda T, Kaneko H, Yamada T, Miyata K, Kiyomura H, Kumegawa M, Hakeda Y.

Calcif Tissue Int. 2000 Jul;67(1):85-92.

PMID:
10908419
11.
12.

Calcitonin inhibits proton extrusion in resorbing rat osteoclasts via protein kinase A.

Kajiya H, Okamoto F, Fukushima H, Okabe K.

Pflugers Arch. 2003 Mar;445(6):651-8. Epub 2003 Jan 14.

PMID:
12632184
13.

Enhanced oxidative stress impairs cAMP-mediated dilation by reducing Kv channel function in small coronary arteries of diabetic rats.

Bubolz AH, Li H, Wu Q, Liu Y.

Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H1873-80. Epub 2005 Jun 3.

14.

Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.

Huang J, Yuan L, Wang X, Zhang TL, Wang K.

Life Sci. 2007 Aug 16;81(10):832-40. Epub 2007 Jul 27.

PMID:
17764702
16.

Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.

Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.

J Cell Physiol. 2003 Jul;196(1):180-9.

PMID:
12767054
17.

The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage.

Kobayashi Y, Ueyama S, Arai Y, Yoshida Y, Kaneda T, Sato T, Shin K, Kumegawa M, Hakeda Y.

J Bone Miner Metab. 2004;22(4):318-28.

PMID:
15221489
18.

Prostaglandin E2 activates outwardly rectifying Cl(-) channels via a cAMP-dependent pathway and reduces cell motility in rat osteoclasts.

Okamoto F, Kajiya H, Fukushima H, Jimi E, Okabe K.

Am J Physiol Cell Physiol. 2004 Jul;287(1):C114-24. Epub 2004 Mar 24.

19.

Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.

El Hajj Dib I, Gallet M, Mentaverri R, Sévenet N, Brazier M, Kamel S.

Eur J Pharmacol. 2006 Dec 3;551(1-3):27-33. Epub 2006 Sep 16.

PMID:
17049513
20.

Supplemental Content

Support Center